SCHEMBL24372549

SCHEMBL24372549

O=C(CS)OCCCc1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 2/20 0.45
TDP1 Q9NUW8 1/20 0.43
FFAR1 O14842 2/20 0.43
NPC1 O15118 1/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
CTDSP1 Q9GZU7 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
KMT2A Q03164 1/20 0.42
MGLL Q99685 4/20 0.41
APOBEC3A P31941 2/20 0.41
APOBEC3G Q9HC16 2/20 0.41
MAPT P10636 1/20 0.41
CYP2D6 P10635 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24372557 0.95 MGLL (0.44) LMNATDP1FFAR1MGLLHDAC2
SCHEMBL24372734 0.90 LMNA (0.53) LMNASMN1; SMN2ALDH1A1TDP1FFAR1
SCHEMBL24372550 0.83 CYP1A2 (0.53) LMNASMN1; SMN2ALDH1A1TDP1NPC1
SCHEMBL24372552 0.83 LMNA (0.46) LMNASMN1; SMN2ALDH1A1TDP1FFAR1
SCHEMBL4457866 0.78 TDP1 (0.56) LMNASMN1; SMN2ALDH1A1TDP1FFAR1
SCHEMBL24372731 0.78 MGLL (0.46) FFAR1MGLLHDAC2
SCHEMBL24372556 0.78 LMNA (0.49) LMNASMN1; SMN2ALDH1A1TDP1FFAR1
SCHEMBL24372546 0.76 L3MBTL1 (0.44) ALDH1A1TDP1FFAR1NPC1RAB9A
SCHEMBL12808247 0.75 LMNA (0.59) LMNASMN1; SMN2ALDH1A1FFAR1NPC1
SCHEMBL28721829 0.74 TDP1 (0.63) LMNASMN1; SMN2ALDH1A1TDP1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127286-A1 LIGANDS FOR NANO-SIZED MATERIALS MERCK PATENT GMBH (DE) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127286-A1 LIGANDS FOR NANO-SIZED MATERIALS L1CAM, EPCAM, SELPLG LMNA 1891/4885SMN1; SMN2 4648/4885ALDH1A1 3030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.